Myocardial necrosis (Ml) after percutaneous coronary intervention (PCI) IS associated with an increased incidence of late adverse outcomes.
Methods:
We conducted a prospective randomized.
placebo-controlled trial in 150 PCI patients to determine whether intracoronary (IC) propranolol ( 0.015mglkg) decreases post -PCI MI and in which subgroups this effect occurs. Results: Post -PCI Ml &K-MB > upper limit of normal) developed in 17% of IC propranolol pts (13/75) and 36% of placebo pts ( 27175) (p=O.Ol). The figure shows that this effect is widely applicable including the subgroup receiving prophylactic GP llbillla inhibitors (28% of pts) and chronic oral pre-PCI beta- healing of these miniature wounds by HOT may decrease restenosis.The following constitutes our interim comparative flndings.
Methods: Of 68 patients Initially enrolled,28 were randomized to the HOT arm and 40 to the control group.The patients underwent PCI for unstable angina or acute myocrdial infarction(Ml) .All patients received at least one stent.Patients in the HOT arm underwent 2 hyperbaric dives using the Sechrist 25008 MonoplaceSystem(Sechrist Inds., Annaheim,CA):one dive 2 hours before or immediately after PCl,and the other withtn 18 hours of the first dive.Each dive consisted of 100% Oxygen at 2 bars for 90 minutes.
Results:
The primary endpoints consisted of major adverse cardiac events at 8 months (Table) .Repeat coronary angiography was performed for chest pain or Ml in 3 patients of the HOT arm and 8 of the control group.Anglographlc restenosis in the target lesion was found in 7of the control and 0 of the HOT arm(p=0.007).
Conclusions:
HOT is a safe and effective adjunct to PCI and IS associated with a signdicant reduction I" the restenosls rate.Furthermore,it substantially reduces recurrence of late angina1 symptoms. The incidence of Ml in the 1": Znd and 3" WBC tertiles was 6.5, 9.6 and 13.8%, respectively (p for trend O.OOlMS) [ Figure] . In a multivariable logistic regression model, increas- In the diagnostic setting, when given on top of ADO, URA (but not PHE) induces a limited further decrease in MR. Yet this changed the clinical decision in only 7 % of pts.
